Raffles Insitutep Xpo - Raffles Medical Group
Raffles Insitutep Xpo - Raffles Medical Group
Raffles Insitutep Xpo - Raffles Medical Group
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ANNUAL REPORT 2004<br />
p21<br />
CORPORATE GOVERNANCE<br />
CORPORATE GOVERNANCE<br />
Corporate Governance Statement<br />
The Directors and Management of <strong>Raffles</strong> <strong>Medical</strong> <strong>Group</strong> (RMG) are committed to comply with the Code of Corporate<br />
Governance (Code) issued by the Corporate Governance Committee in March 2001 so as to ensure greater transparency and<br />
protection of shareholders’ interests. This statement outlines the main corporate governance practices that were in place throughout<br />
the financial year. The Company has generally complied with the principles of the Code.<br />
The Board’s Conduct of its Affairs<br />
RMG’s Board of Directors’ (the Board) primary role is to protect and enhance long-term value of all RMG’s shareholders. It sets<br />
the overall strategy for the <strong>Group</strong> and supervises Senior Management. To fulfil this role, the Board is responsible for the overall<br />
corporate governance of the <strong>Group</strong> including setting its strategic direction, establishing goals for Management and monitoring<br />
the achievement of these goals.<br />
The Board currently holds four scheduled meetings each year. In addition, the Directors meet to discuss strategy and hold<br />
extraordinary meetings at such other times as may be necessary to address any specific significant matters that may arise. We<br />
have disclosed the attendance of the Directors at Board Meetings and Board Committees, as well as the frequency of such<br />
meetings in the Report.<br />
The Board has decided that certain matters must always be approved by the Board. These include:<br />
• approval of quarterly results announcements;<br />
• approval of the annual report and accounts;<br />
• declaration of interim dividends and proposal of final dividends;<br />
• convening of Shareholders’ Meetings;<br />
• approval of corporate strategy and direction of the <strong>Group</strong>;<br />
• material acquisition or disposal;<br />
• approval of transactions involving a conflict of interest for a substantial shareholder or a Director or interested person<br />
transactions; and<br />
• appointment of new Directors<br />
All other matters are delegated to Committees whose actions are reported to and monitored by the Board.<br />
Training of Directors<br />
All new Directors are given briefing sessions on the operations of all the key businesses and support units. Prior to their<br />
appointment, new Directors are provided with relevant information on their duties as Directors under Singapore law. Directors<br />
are also updated regularly on accounting and regulatory changes.<br />
Directors may at any time request further explanation, briefing or informal discussion on any aspects of the Company’s operations.<br />
Board Composition and Balance<br />
The names of the Directors of the Company in office at the date of this Statement are set out below.<br />
The Board has reviewed its composition and is satisfied that such composition is appropriate. The Board constantly examines<br />
its size with a view to determine the impact upon its effectiveness.